165 related articles for article (PubMed ID: 30051771)
41. Exploring binding modes of the selected inhibitors to phosphodiesterase delta by all-atom molecular dynamics simulations and free energy calculations.
Zhong H; Zhang YJ; Shan XB
J Biomol Struct Dyn; 2019 Jun; 37(9):2415-2429. PubMed ID: 30052144
[TBL] [Abstract][Full Text] [Related]
42. TEAD4 as an Oncogene and a Mitochondrial Modulator.
Hsu SC; Lin CY; Lin YY; Collins CC; Chen CL; Kung HJ
Front Cell Dev Biol; 2022; 10():890419. PubMed ID: 35602596
[TBL] [Abstract][Full Text] [Related]
43. Molecular dynamics investigations of structural and functional changes in Bcl-2 induced by the novel antagonist BDA-366.
Li T; Cui Y; Wu B
J Biomol Struct Dyn; 2019 Jul; 37(10):2527-2537. PubMed ID: 30047840
[TBL] [Abstract][Full Text] [Related]
44. VGLL4 promotes vascular endothelium specification via TEAD1 in the vascular organoids and human pluripotent stem cells-derived endothelium model.
Quan Y; Hu M; Jiang J; Jin P; Fan J; Li M; Fan X; Gong Y; Yang Y; Wang Y
Cell Mol Life Sci; 2023 Jul; 80(8):215. PubMed ID: 37468661
[TBL] [Abstract][Full Text] [Related]
45. Insight into the binding modes of Lassa nucleoprotein complexed with ssRNA by molecular dynamic simulations and free energy calculations.
Zhang Y; Chen H; Han JG
J Biomol Struct Dyn; 2015; 33(5):946-60. PubMed ID: 24824824
[TBL] [Abstract][Full Text] [Related]
46. An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors.
Xie H; Li Y; Yu F; Xie X; Qiu K; Fu J
Int J Mol Sci; 2015 Nov; 16(11):27350-61. PubMed ID: 26580609
[TBL] [Abstract][Full Text] [Related]
47. Mutagenesis of DsbAss is Crucial for the Signal Recognition Particle Mechanism in
Durrani FG; Gul R; Mirza MU; Kaderbhai NN; Froeyen M; Saleem M
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 30987187
[TBL] [Abstract][Full Text] [Related]
48. Structural and functional analysis of the YAP-binding domain of human TEAD2.
Tian W; Yu J; Tomchick DR; Pan D; Luo X
Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7293-8. PubMed ID: 20368466
[TBL] [Abstract][Full Text] [Related]
49. Mechanistic insights into the activity of Ptf1-p48 (pancreas transcription factor 1a): probing the interactions levels of Ptf1-p48 with E2A-E47 (transcription factor E2-alpha) and ID3 (inhibitor of DNA binding 3).
Topno NS; Kannan M; Krishna R
J Biomol Struct Dyn; 2018 May; 36(7):1834-1852. PubMed ID: 28571517
[TBL] [Abstract][Full Text] [Related]
50. Molecular mechanism of inhibitor bindings to bromodomain-containing protein 9 explored based on molecular dynamics simulations and calculations of binding free energies.
Wang Y; Wang LF; Zhang LL; Sun HB; Zhao J
SAR QSAR Environ Res; 2020 Feb; 31(2):149-170. PubMed ID: 31851834
[TBL] [Abstract][Full Text] [Related]
51. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.
Shen M; Zhou S; Li Y; Pan P; Zhang L; Hou T
Mol Biosyst; 2013 Mar; 9(3):361-74. PubMed ID: 23340525
[TBL] [Abstract][Full Text] [Related]
52. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
Chaudhari HK; Pahelkar A
Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
[TBL] [Abstract][Full Text] [Related]
53. Discovery of a latent calcineurin inhibitory peptide from its autoinhibitory domain by docking, dynamic simulation, and in vitro methods.
Harish BM; Saraswathi R; Vinod D; Devaraju KS
J Biomol Struct Dyn; 2016 May; 34(5):983-92. PubMed ID: 26111023
[TBL] [Abstract][Full Text] [Related]
54. A Molecular Modeling Study of the Hydroxyflutamide Resistance Mechanism Induced by Androgen Receptor Mutations.
Liu HL; Zhong HY; Song TQ; Li JZ
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28832499
[TBL] [Abstract][Full Text] [Related]
55. Prediction of GluN2B-CT
Tu G; Fu T; Yang F; Yao L; Xue W; Zhu F
Molecules; 2018 Nov; 23(11):. PubMed ID: 30463177
[TBL] [Abstract][Full Text] [Related]
56. A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis.
Li L; Ugalde AP; Scheele CLGJ; Dieter SM; Nagel R; Ma J; Pataskar A; Korkmaz G; Elkon R; Chien MP; You L; Su PR; Bleijerveld OB; Altelaar M; Momchev L; Manber Z; Han R; van Breugel PC; Lopes R; Ten Dijke P; van Rheenen J; Agami R
Genome Biol; 2021 Jan; 22(1):54. PubMed ID: 33514403
[TBL] [Abstract][Full Text] [Related]
57. 3D-QSAR-aided design of potent c-Met inhibitors using molecular dynamics simulation and binding free energy calculation.
Balasubramanian PK; Balupuri A; Bhujbal SP; Cho SJ
J Biomol Struct Dyn; 2019 May; 37(8):2165-2178. PubMed ID: 30044205
[TBL] [Abstract][Full Text] [Related]
58. Computational revelation of binding mechanisms of inhibitors to endocellular protein tyrosine phosphatase 1B using molecular dynamics simulations.
Yan F; Liu X; Zhang S; Su J; Zhang Q; Chen J
J Biomol Struct Dyn; 2018 Nov; 36(14):3636-3650. PubMed ID: 29048995
[TBL] [Abstract][Full Text] [Related]
59. Interaction Entropy for Computational Alanine Scanning.
Yan Y; Yang M; Ji CG; Zhang JZH
J Chem Inf Model; 2017 May; 57(5):1112-1122. PubMed ID: 28406301
[TBL] [Abstract][Full Text] [Related]
60. Conformational and energy evaluations of novel peptides binding to dengue virus envelope protein.
Amir-Hassan A; Lee VS; Baharuddin A; Othman S; Xu Y; Huang M; Yusof R; Rahman NA; Othman R
J Mol Graph Model; 2017 Jun; 74():273-287. PubMed ID: 28458006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
